Matt Schumacher is the Agility Enablement Lead at UCB Inc. supporting national leadership for the connectivity between UCB and health systems to catalyze new solutions for patients with epilepsy. Prior he was the Patient Mission Lead for New England. He has served on the movement marketing team focused on developing resources for patients suffering from Parkinson's disease and was commercial lead for neurology in New England. Prior to that, Matt provided leadership at Sanofi to sales teams for 10 years. His professional experience includes development and fundraising at Colby College as Major Gift Officer and Harvard Business School as Assistant Director of the HBS Fund.
Matt earned his B.A. in Biochemistry, with distinction, from Wheaton College (MA) in 1998. Matt currently serves on the Yarmouth, Maine Planning Board. His past civic involvement include the Yarmouth Historical Society and American Institute of Graphic Arts.